Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07117422Not ApplicableRecruiting

Venetoclax-Decitabine in Untreated Elderly/Unfit AML

Role: collaborator

NCT06783933Active Not Recruiting

Artificial Intelligence-assisted Diagnosis

Role: collaborator

NCT06175156Not ApplicableCompleted

Application of Propofol Mixed With Remifentanil in Fiber Colonoscopyand Analgesia in Fiber Colonoscopy

Role: lead

NCT05712785Not ApplicableRecruiting

Shuotongo Ureteroscopy for Upper Urinary Tract Stones

Role: lead

NCT05633680Unknown

Circulating Tumor Cells Screen for Breast Cancer

Role: lead

NCT02983851Not ApplicableUnknown

Initial Ventilation Strategy for Adult Immunocompromised Patients With Acute Respiratory Failure

Role: collaborator

NCT02094638Completed

Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study

Role: collaborator

NCT00548223Phase 4Completed

The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule

Role: collaborator

All 8 trials loaded